v Cerebral vasospasm was induced in adult mongrel dogs by a two-hemorrhage method. The basilar arteries were quickly frozen after careful removal of surrounding blood clot and their level of immunoreactive endothelin-I, a strong vasoconstrictor produced by the endothelial and vascular smooth-muscle cells, was measured by sandwich-enzyme immunoassay. The levels of immunoreactive endothelin-I (mean ± standard deviation) were 112.9 ± 7.0 pg/mg protein prior to vasospasm, 180.4 ± 24.7 pg/mg protein on Day 2 after vasospasm, and 115.0 ± 24.0 pg(mg protein on Day 7, showing a significant increase (p < 0.01) in immunoreactive endothelin-I only on Day 2. In addition, vasospasm was moderately reversed by the topical application of monoclonal antibody against endothelin-I on Day 2 but rather resistant to topical monoclonal antibody on Day 7. It is suggested that endothelin-I could act as a trigger in the early stages of cerebral vasospasm, but that the maintenance of cerebral vasospasm at later stages might be independent of endothelin-l.
NDOTHELIN-l, one of three distinct isopeptides in the endothelin family,9 is produced by the endothelial cells,28 and has been shown to induce a strong and prolonged vasocontraction,28 including that of the cerebral artery in vitro and in vivo. 2 • 8 ,'5,21 In addition, the plasma concentration of endothelin-l increases significantly for 3 to 14 days after subarachnoid hemorrhage (SAH), and significantly more so on Day 7 when SAH is accompanied by vasospasm. 14 Recently, cultured human vascular smooth-muscle cells have been reported to elicit the synthesis of endothelin-I by vasoactive hormones and growth factors, '7 It is suggested, therefore, that endothelin-l might be one of the candidates responsible for the development of cerebral vasospasm. In this study, we examine both the levels of immunoreactive endothelin-l in the canine basilar artery in vasospasm, and the response of vasospasm to the topical application of monoclonal antibody against endothelin-l. We discussed the role of endothelin-l in the development of cerebral vasospasm.
Materials and Methods

Cerebral Vasospasm Model
The care of animals in this study complied with the standards laid down by the United States Public Health Service. Adult mongrel dogs, each weighing II to 16 kg, were sedated with intramuscular ketamine hydro-chloride (10 mg/kg) followed by intravenous pentobarbital sodium (15 mg/kg). After endotracheal intubation, arterial CO 2 tension was kept at 32 ± 2 torr by adjusting the respiratory pump or by adding CO 2 to the inspired gas, and body temperature was maintained close to 37°C with a heating blanket. Mean arterial blood pressure (MABP) and pulse rate were monitored continuously via the femoral artery, A baseline vertebral angiogram was obtained with femoral artery injection, then experimental SAH was produced by two successive injections 2 days apart, each of 5 ml fresh autogenous arterial blood into the cisterna magna, as described by Varsos, et af. 26 Vertebral angiography was repeated before the animals were sacrificed; the caliber of the basilar artery was measured at its narrowest point on the magnified angiogram and expressed as a percentage of the control caliber. The animals were perfused with 500 ml saline for sandwich-enzyme immunoassay before sacrifice, 2 days (Day 2) or 7 days (Day 7) after the first injection of blood. The Day 2 animals received single injections, while those killed on Day 7 received two injections of blood.
Tissue Extraction Procedure
The basilar artery was removed together with the entire brain. Blood clot around the spastic basilar artery and its branches was meticulously removed without mechanical stimulation to the spastic basilar artery. After a brief washing with warm saline, the basilar artery was quickly frozen in liquid nitrogen until used. The normal basilar arteries underwent a similar procedure. The basilar artery was homogenized with Polytron PT 10-55* for 1 minute in 1.0 M acetic acid containing pepstatin (10 ,ug/ml), and immediately boiled for 10 minutes. The homogenate was centrifuged at 25,000 G for 10 minutes at 4°C, and the supernatant was applied to a Sep-pak CI8 cartridge.t The absorbed peptides were eluted with acetic acid/ethanol/water (4:86:10) and concentrated at 37"C under a nitrogen gas stream. The residual materials were vigorously shaken for 5 seconds* after the addition of ethanol, and dried at 37°C under a nitrogen gas stream. Thereafter, they were again agitated for 10 seconds after the addition of buffer E (0.02 M phosphate buffer, pH 7.0, containing 0.4 M NaCl, 2 mM ethylenediaminetetra-acetic acid (EDT A), 10% Block Ace, 0.2% bovine serum albumin, and 0.05% NaN 3 ). The residua were again agitated for 3 seconds after ultrasonic treatment for 10 minutes, and finally centrifuged at 12,000 G for 5 minutes. The supernatant was subjected to sandwich-enzyme immunoassay. The protein content of the basilar artery extract was determined by Bradford's technique. 
Sandwich-Enzyme Immunoassay for Endothelin-l
Sandwich-enzyme immunoassay for endothelin-l has been described in detail elsewhere. 25 Briefly, mouse monoclonal antibody, AwETN40 (immunoglobulin G" K), which recognizes the N-terminal loop domain of endothelin-I, 24 was used as an immobilized antibody. Rabbit antibodies against endothelin-I C-terminal peptide Fab' were conjugated with horseradish peroxidase 24 and used as enzyme-labeled antibodies. Antibody-coated microtest plates were prepared by adding 20 ,ug/ml (100 ,ul) of AwETN40 to each well, followed by 300 ,ul of block solution (phosphate-buffered saline (PBS), pH 7.2, containing 25% Block Ace and 0.1 % NaN 3 ). Standard endothelin-l and samples of basilar artery in 100 III of buffer E were added to each well of the AwETN40-coated microtest plate and incubated at 4°C for 24 hours. After washing with PBS, the plate was exposed to 100 ,ul horseradish-labeled anti-endothelin-I Fab' at 4°C for 24 hours. After a further washing with PBS, the bound enzyme activity was measured using o-phenylenediamine as a chromogen with a microplate reader. § The levels of immunoreactive endothelin-l on Day 2 and Day 7 were statistically analyzed by Student's t-test. 
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Adsorption of Immunoreactive Endothelin-l by AwETN40
The extract of normal or spastic basilar artery (0.5 mIl was treated at 4°C for 4 hours with 50 ,ug immobilized AwETN40 (1.5 mg of AwETN40 coupled with 1 gm of CNBr-activated Sepharose 4B).11 After the mixture was centrifuged twice at 1500 G for 10 minutes, the supernatant was subjected to sandwich-enzyme immunoassay with AwETN40.
Chromatographic Analysis
The extract of normal or spastic basilar artery was characterized by reverse-phase high-performance liquid chromatography on a 4.6 x 250-mm column.* The solvents used were either 5% CH 3 CN containing 0.05% trifluoroacetic acid or 60% CH 3 CN containing 0.05% trifluoroacetic acid. In the elution, the concentration of the second solvent was elevated linearly from 0% to 40% over 5 minutes, from 40% to 65% over 20 minutes, and then from 65% to 100% over 5 minutes, at a flow rate of 1.0 ml/min. Fractions were lyophilized and subjected to sandwich-enzyme immunoassay with AwETN40.
Effect of Topical AwETN40 on Vasospasm
After angiographic confirmation of cerebral vasospasm in the Day 2 and Day 7 groups, the spastic basilar artery was exposed by gently removing the clivus and by careful incision of dura and arachnoid under an operating microscope. Blood ,clot around the spastic basilar artery and its branches was removed meticulously without any mechanical stimulation to the artery, and the operative field was briefly washed with warm saline. After the artery was photographed, dose-response measurements were obtained after the topical application of successively increasing concentrations of AwETN40 or nonimmune mouse serum. Dose concentrations were increased by a factor of about three, and each was applied while the previous dose remained in contact with the basilar artery. At the end of each experiment, 4 mM ethyleneglycol-bis-(,6-amino-ethylether)-N,N' -tetra-acetic acid (EGTA) was added for the purpose of analysis. The mean diameter of spastic basilar artery was calculated by measurement at three predetermined levels, and expressed as a percentage of the relaxation induced by EGT A. The percentage relaxations induced by AwETN40 on Day 2 and Day 7 were statistically analyzed by Student's t-test. Antibody AwETN40 and nonimmune mouse serum were dissolved in PBS before use, and the final concentration of PBS had no effect on the caliber of the spastic basilar artery.
II CNBr-activated Sepharose 4B obtained from Pharmacia LKB Biotechnology AB, Uppsala, Sweden.
* Column TSK ODS-80TM liquid chromatography obtained from Tosoh Corp., Tokyo, Japan.
Results
Cerebral Vasospasm Model
The angiographic calibers of the basilar arteries used for sandwich-enzyme immunoassay were means ± standard deviations: 70.3% ± 4.0% in eight animals on Day 2 and 51.8% ± 5.3% in eight animals on Day 7, as compared to the mean control caliber (Table I) . A representative vertebral angiogram of vasospasm in an animal sacrificed on Day 2 is shown in Fig. 1 .
Sandwich-Enzyme Immunoassay for Endothelin-l
A standard curve for endothelin-l is shown in Fig. 2 
Adsorption of Immunoreactive Endothelin-l by AwETN40
When the extract of normal or spastic basilar artery was treated with immunosorbents of AwETN40, immunoreactive endothelin-l was almost completely adsorbed. This suggests the production of immunoreactive endothelin-I by the basilar artery.
Chromatographic Analysis
On chromatographic analysis, immunoreactive endothelin-I appeared at the elution position corresponding to synthetic endothelin-l in normal and spastic basilar arteries (Fig. 3) . No immunoreactivity was detected at the elution position of synthetic endothelin-2. The minor endothelin immunoreactivity at 18 minutes might represent an oxidation product of endothelin-I, as suggested by Suzuki, et af.2 4 
Response of Spastic Basilar Artery to Topical AwETN40
The angiographic calibers of basilar arteries used were 71.1 % ± 2.7% in five animals studied on Day 2 102 I. Yamaura, et at. and 58.0% ± 6.2% in five animals studied on Day 7, as compared to the mean control caliber. The responses of exposed spastic basilar arteries to a topical application of I x 10-10 to 3 X 10-6 M AwETN40 are shown in situ in Fig. I and as logarithmic dose-response curves in Fig. 4 . The relaxation induced by 4 mM EGTA was taken as 100%. The spastic basilar arteries on Day 2 were moderately dilated in a dose-dependent manner by AwETN40, and the value of maximum effect by AwETN40 was 42.7% ± 3.9% at 1 x 10-6 M. In contrast, the spastic basilar arteries on Day 7 were only slightly dilated in a dose-dependent fashion by A wETN40, and the value of maximum response to AwETN40 was 17.7% ± 1.5% at 3 x 10- 
Discussion
Molecular Structure of Endothelin
Preproendothelin, a precursor of endothelin, is transformed into big endothelin, which can be acted on by endothelin-converting enzyme, resulting in the formation of endothelin. 28 The endothelin molecule is divided into two sections: the N-terminal 15 amino acids have a rigid structure with two disulfide bonds and the following C-terminal hexapeptide consists of relatively hydrophobic amino acids 24 (Fig. 5 ). In addition, three endothelins with different amino acid sequences have been identified: endothelin-l, -2, and _3. 9 These amino acid sequences are well conserved among species and are identical in humans and dogs. 20 
Specificity of Sandwich-Enzyme Immunoassay
The sandwich-enzyme immunoassay techniques require two sets of antibodies that separately recognize J. Neurosurg. / Volume 76/ January, 1992 the N-terminal and the C-terminal portions of endothelin-I. The monoclonal antibody AwETN40, used as an immobilized antibody, recognizes the N-terminal loop domain of endothelin-I but does not react with the endothelin-l C-terminal heptapeptide; however, horseradish-labeled anti-endothelin-I Fab' recognizes the C-terminal peptide 24 (Fig. 5) . The present sandwichenzyme immunoassay was accurate and reproducible 25 and the adsorption study indicated that the assay detected immunoreactive endothelin. Suzuki, et al_,24 reported that the sandwich-enzyme immunoassay used in the present study also fully reacted with endothelin-2, but not with either endothelin-3 or big endothelin-I (cross-reactivity was < 0.5% in each case). However, chromatographic analysis showed that the canine basilar artery actually did not synthesize endothelin-2 under normal conditions and during vasospasm. In addition, Northern dot analysis demonstrates an expression of only endothelin-l messenger ribonucleic acid in the endothelial cells. 27 
Pharmacological Function of Endothelin-l
The isolated canine basilar arteries are reported to contract in a dose-dependent manner in response to endothelin-l,2.8 their maximum tension is larger than that induced by 40 mM KCl and the molar concentration at 50% contraction value (ED so, means ± standard deviations) is 1.9 ± 0.6 x 10-9 M. The vasoconstrictive response to endothelin-l is resistant to the following antagonists: a-adrenergic, HI-histaminergic, serotonergic, cyclo-oxygenase, and lipoxygenase;28 this suggests that endothelin-l acts on its own receptor on the vascular smooth-muscle cells.
The endothelin-l-induced vasocontraction is completely inhibited when the washing solution is replaced with Ca++ -free Krebs-Ringer solution containing 1 mM EGTA immediately before the addition of 10-9 M endothelin-l. 28 In addition, the vasocontraction is markedly attenuated in the presence of a Ca++ channel blocker, nicardipine. 28 Also, endothelin-l stimulates phospholipase C to cause phosphoinositide breakdown, leading to intracellular Ca++ mobilization and protein kinase C activation.I.7.'I.'3.' 6.18.19.22.23 It is suggested, therefore, that phospholipase C-mediated phosphoinositide breakdown, as well as activation of voltage-dependent Ca++ channels might be involved in the mechanism of endothelin-I-induced vasocontraction.
Role of Endothelin-l in Development of Vasospasm
Endothelin-l is shown to induce a strong and prolonged contraction of the cerebral artery in vitro and in vivo. 2 ,8.15 , 21 An infusion of up to 3.0 nM endothelin-1 into the vertebral artery has no appreciable effect on the caliber of normal canine basilar artery,15 but an intracisternal injection of 0.6 to 1.2 pmol/kg of endothelin-l causes a biphasic contraction of normal canine basilar artery lasting for more than 24 hours. 2 , 8 The immunoreactive endothelin-Ilevels in the basilar arteries were significantly increased on Day 2 and not significantly changed on Day 7, based on the measurements both per milligram protein and per milligram wet tissue. This suggests that endothelin-l might be involved in the development of vasospasm on Day 2.
In addition, pretreatment with a 10-fold molar excess of AwETN40 decreases the tension induced in a porcine coronary artery strip by 10 nM endothelin-l from 78% ± 30% to 8.3% ± 3.6% of that elicited with 60 mM KCI. 25 The moderate effectiveness of topical AwETN40 for the reversal of vasospasm on Day 2 might suggest that endothelin-l is partly responsible for the development and maintenance of vasospasm, but the fact that the maximum effect of AwETN40 is not as high suggests that other factors must be taken into consideration. On the other hand, although the immunoreactive endothelin-I level of basilar artery on Day 7 was significantly lower than that on Day 2, the effectiveness of topical AwETN40 for the reversal of vasospasm was only slight on Day 7. It is suggested, therefore, that factors responsible for the development and maintenance of vasospasm on Day 2 can be divided into both endothelin-I-responsive and endothelin-I-independent components, whereas vasospasm on Day 7 might be totally independent of endothelin-l.
Mechanism of Increased Endothelin-l in Basilar Artery
The levels of endothelin-l production from the endothelial cells are regulated by several substances including thrombin, transforming growth factor (3, arginine-vasopressin, and angiotensin II. 5 .'2,28,29 Compounds eliciting the synthesis of endothelin-I in cultured human vascular smooth-muscle cells include angiotensin II, arginine-vasopressin, transforming growth factor (3, platelet-derived growth factor AA, and epidermal growth factor.17 The endothelin-l induction proc-104 I. Yamaura, et at. ess in human vascular smooth-muscle cells exhibits transient kinetics that differ from the more sustained induction process observed for porcine endothelial cells. 17 The amounts of endothelin-l secreted by angiotensin II-and arginine-vasopressin-stimulated human vascular smooth-muscle cells are about 40% lower ' ? than those reported for similarly stimulated endothelial cells. 5 The mechanism for the increase of endothelin-l in the basilar artery on Day 2 remains unknown, but the increase might result from excessive local production of endothelin-I-inducing substances. An increased release of arginine-vasopressin in the cerebrospinal fluid is reported to be involved in the development of acute cerebral vasospasm,4 whereas angiotensin II participates in the development of delayed cerebral vasospasm. 6 Alternatively, since the human endothelin-I gene contains a consensus sequence for acute-phase reactant elements, IO the increased endothelin-l production might be attributable to stress-induced release of an acute-phase reactant during SAH; however, it is difficult to explain the localized increased production of endothelin-l in the basilar artery. The hemodynamic shear stress along the luminal side of endothelial cells might be increased when the basilar artery is contracted, and this may stimulate endothelin-l production by endothelial cells. 30
